Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice PeteRose and to all with such gains. Sad to say I'm only at 157.55%. LOL only!!!! Soon true longs can add a couple more zeros.
$7-$8 would still be a bargain. The others would be easier to market which would drastically increase the PPS.
Your info is an opinion without links. No links=no proof=false information.
I'm going to believe the CEO who is liable and can be charged with violating Federal Laws, Sar/Ox, over a message board poster...LOL!!!!
I also don't believe that they would take a client without knowing or believing they could get their clients drug(s) approved. You want a 505b2 approved, they are the firm to get it done. Why would they risk their reputation on a small pharmaceutical company? They won't because they know ELTP's tech is legit.
DZ that is for one launched drug with ART. The CEO wants a complete line of opiates and they are working towards it by conducting three separate trials for three different drugs. Exciting times!
Thanks bud! Our DD kings always provide the links to back up their claims.
Welcome aboard. There are many here that can provide the correct info and they're shareholders as well. Don't be afraid to ask a question.
Look it up... Info is readily available.
Same claim that ELTP didn't have enough cash to do the trials to begin with. We know how that went. All pharmaceutical companies conduct "puny" trials at one point so exactly what is your point?
That's for one drug with ELTP's ART...now imagine three or four? Once ELTP gets one out it will be so much easier to get the whole line of products to market. $4-$4.50 is to low imo.
IMO ELTP is going to surprise us all with their revenues, drug launches, more milestone payments, NOVELL Labs 10% ownership sale, partnership, more patents, ect..
I asked the question in the last CC that if all the stars aligned when is the earliest drug that utilizes their ART is going to be launched and HAKIM said Dec/2015. He was quick to point out that the FDA had a duty to look at all the info within one year due to the cost that ELTP was paying. Dec/2014 for an (A)NDA application and Dec/2015 for approval BUT IMO the biggest surprise will come much sooner due the epidemic that is plaguing this country with the opiate problem. The FDA wants ART drugs on the market and ELTP has the best tech! I can't wait for the first because the others will come faster.
Well Laser you've been on target and another milestone payment for another drug transfer is a sure bet. My investment in ELTP keeps getting better.
Another milestone payment for another drug launch? The revenues continue to climb!
Thanks for the welcoming party and I hope we are all heading to Vegas soon! Anyone not in ELTP will be missing out in a once in a lifetime opportunity. Buy buy buy!!
I was expecting another consolidation to .20 but am delightfully surprised how well the stock is moving. With Monday being closed I wouldn't be surprised with a late power hour surge by many that don't want to be left out incase a PR pops on Tuesday.
Us true longs support ELTP on green days and red. Unfortunately you have some claiming to be true longs that will only support the stock on green days. The red days from these so called true longs will find excuses on why not to buy ELTP.
POORME: PPS UPDATE PLEASE! EOM.
Couch my friend i received your PM. Will upgrade tomorrow and hope this sites lvl2 is worth it.
Or any news for that matter. Tues/Thurs are solid days for ELTP to put out news and this could be an anticipation for tomorrow. Some might not want to sit out and miss a possible PR. W/E the reason it's a good time to be an ELTP investor.
And as other true longs have posted, great consolidation in this range so ELTP can move higher. Can't wait for the next news to hit!
EXACTLY my point thank you for clarifying that. The poor choice of words don't exactly help the credibility factor.
Problem is the typical investor usually comes back and continues to rant about all the problems ELTP has while never selling the shares at the price target that was stated and was achieved. Forgiveness is never the issue...
Someone claimed to sell at .125 for a loss and at .15-.16 for another loss in another account, remember? The mountain of selling never occurred. So I wonder what the next sell price target is going to be? Would you care to guess? Don't know about you but I'm keeping my shares of ELTP.
I agree Poorme, buying and selling stock based on taking investment advice from message board posters is a bad idea. One would think doing some personal DD and taking responsibility for one's actions would be ideal.
I'll take a slow steady climb! We all know what's coming--ART!
You're right Conix but I predict new highs once a partner like Actavis, J&J, Merck, PFE, Purdue, ect..is announced. Novel sale would also set new highs as that would be an immediate cash infusion and/or transfer of an ANDA to ETLP as part of the sale. So much news that can hit any day. Also keep in mind about the next patent although past patent news had little impact on the stock. Of course that was before the R/R Conference so now a patent news might take the stock higher with more investors keeping an eye on ELTP.
And yet you didn't sell at any of those prices but instead continued to buy. You had nearly a week to sell at 14.5-16.8 range.
Just want to thank all The True Longs for their continued support and DD on ELTP. You guys make it easy to want to invest in ELTP and to continue on with the buy, hold, accumulate strategy. In a couple of years it will payoff in huge profits with the ART drugs that will be launched.
Some might see it as a weakness but I see a stronger company which reflects their PPS. As the company grows each day our PPS will only climb and we'll be looking back at .115 laughing. I'll be buying more tomorrow when funds hit. News can strike any day and there is just too much of it to sit on the sidelines.
Well then that would make you a trader would it not? Def. not part of the buy, hold accum. group...a TRUE LONG.
The facts are US TRUE LONGS have always bought on the dips and some have bought on the rise.
LOL i'm right there with ya although I saw the new Corvette and might pass on the R8 for it and keep the change:) Either way once ELTP launches it's first ART drug you and I will both be very happy to write those checks out.
US true longs will continue to buy even in the .10 range. Thanks for pointing out the obvious to US true longs.
So now it's ok to have billions of shares for one company but not millions for another? ELTP is about to hit CFP with it's current products and that doesn't include the additional products they picked up from Mikah. That also doesn't include their 10% stake in Novel and/or their ART. C had to go into debt, BILLIONS, to grow their business and that's ok with you but not for ELTP? Help me understand why the double standard?
I have no doubts that this management team will do what it takes, minus a R/S, to get us to another exchange and out of the OTCBB. All it takes is revenues plus growth and we're already seeing that minus the ART drug(s). A select few worried and talking about a 480M OS and yet that is nothing compared to other stocks like SIRI, PFE, and C which has BILLIONS of shares outstanding. I believe C at one point had 27 Billion shares before their R/S and even after they still have billions. I'll take a 480M-500M share count if it means producing just one ART drug that the FDA loves.
I work for a health insurance company and I can tell you that ELTP's tech, once approved and launched by the FDA, will be very welcomed.
I agree and that's why I'm still buying and holding. But I admit that the idea of flipping to quickly gain more shares is enticing.
Conix,
I had a missed opportunity to sell some shares in the .155-.165 range and buy back at these levels to try and pick up more shares. My fear is that I will end up chasing the stock if it actually continued to add more PR's with substantial positive news. If there is another "run" I might actually take half my position and sell and wait for a good buy back entry point. I'm not a trader and doing that will be risky for me, but the way you make it sound, the rewards could also be greater.
If there is a R/S I will be selling my entire position. I've seen quite a few R/S occur only for the stock to tank back to the same levels before the R/S.
Now with that said, a R/S won't be needed once the first ART drug is launched. The revenues will be enough from that one drug to get us on a different exchange. The CEO's goal is not to just have one ART drug but a whole line of ART drugs. That doesn't include what is already being sold and any future dealings with other pharma companies. The sale of Novel alone would pay off all debt, only $5M roughly, and finance all necessary P3 trials. The company could also buy additional ANDA's and sell overlapping ANDA's that they own. Talk of a R/S is a tactic to scare investors away and to get shareholders to sell their shares.
ELTP doesn't need a r/s to make it to a different exchange. One ART drug launch will take the PPS to $4 a share with the current share structure per the CEO. Now imagine four or five ART drugs? That doesn't include the 30+ drugs launched/pipeline.